Company / FCF Margin
Arcturus Therapeutics Holdings Inc. FCF Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-90.8%
FY2025
5-year range
-1120.2% / -12.6%
FY2021-FY2025
Trend
-129.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -12.6% to -90.8% over the past 2 years.
Based on SEC 10-K filings.
-90.8% in FY2025 with a 5-year CAGR of +50.3%.
Declined from -12.6% to -90.8% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +1029.4pp
- 5-Year Change
- +50.3pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin decreased 129.1% year-over-year.
- Peak fcf margin was recorded in FY2023.
- Lowest fcf margin in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -90.8% | -129.1% |
| FY2024 | -39.6% | -214.9% |
| FY2023 | -12.6% | +98.9% |
| FY2022 | -1120.2% | +0.0% |
| FY2021 | -1120.2% | -693.5% |
| FY2020 | -141.2% | +0.0% |
| FY2019 | -141.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026